These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31614328)

  • 1. The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting.
    Brinkley-Rubinstein L; Peterson M; Clarke J; Macmadu A; Truong A; Pognon K; Parker M; Marshall BDL; Green T; Martin R; Stein L; Rich JD
    Drug Alcohol Depend; 2019 Dec; 205():107514. PubMed ID: 31614328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-release treatment uptake among participants of the Rhode Island Department of Corrections comprehensive medication assisted treatment program.
    Martin RA; Gresko SA; Brinkley-Rubinstein L; Stein LAR; Clarke JG
    Prev Med; 2019 Nov; 128():105766. PubMed ID: 31279770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island.
    Peterson M; Macmadu A; Truong AQ; Rich J; Pognon K; Lurie M; Clarke JG; Brinkley-Rubinstein L
    J Subst Abuse Treat; 2019 Nov; 106():73-78. PubMed ID: 31540614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "One guy goes to jail, two people are ready to take his spot": Perspectives on drug-induced homicide laws among incarcerated individuals.
    Peterson M; Rich J; Macmadu A; Truong AQ; Green TC; Beletsky L; Pognon K; Brinkley-Rubinstein L
    Int J Drug Policy; 2019 Aug; 70():47-53. PubMed ID: 31082662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing death among the recently incarcerated: an argument for naloxone prescription before release.
    Wakeman SE; Bowman SE; McKenzie M; Jeronimo A; Rich JD
    J Addict Dis; 2009; 28(2):124-9. PubMed ID: 19340674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration.
    Kaplowitz E; Truong A; Macmadu A; Berk J; Martin H; Burke C; Rich JD; Brinkley-Rubinstein L
    J Addict Med; 2023 Jan-Feb 01; 17(1):54-59. PubMed ID: 35916404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief video intervention to improve attitudes throughout medications for opioid use disorder in a correctional setting.
    Lam JA; Lee HIS; Truong AQ; Macmadu A; Clarke JG; Rich J; Brockmann B
    J Subst Abuse Treat; 2019 Sep; 104():28-33. PubMed ID: 31370982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "It's probably going to save my life;" attitudes towards treatment among people incarcerated in the era of fentanyl.
    Kaplowitz E; Macmadu A; Green TC; Berk J; Rich JD; Brinkley-Rubinstein L
    Drug Alcohol Depend; 2022 Mar; 232():109325. PubMed ID: 35114617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
    Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
    Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medications for opioid use disorder in state prisons: Perspectives of formerly incarcerated persons.
    Treitler PC; Enich M; Reeves D; Crystal S
    Subst Abus; 2022; 43(1):964-971. PubMed ID: 35420973
    [No Abstract]   [Full Text] [Related]  

  • 14. A mapping review of take-home naloxone for people released from correctional settings.
    Horton M; McDonald R; Green TC; Nielsen S; Strang J; Degenhardt L; Larney S
    Int J Drug Policy; 2017 Aug; 46():7-16. PubMed ID: 28575724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release naltrexone for opioid use disorder started during or following incarceration.
    Lincoln T; Johnson BD; McCarthy P; Alexander E
    J Subst Abuse Treat; 2018 Feb; 85():97-100. PubMed ID: 28479011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges to implementing opioid substitution therapy in Ukrainian prisons: Personnel attitudes toward addiction, treatment, and people with HIV/AIDS.
    Polonsky M; Azbel L; Wickersham JA; Taxman FS; Grishaev E; Dvoryak S; Altice FL
    Drug Alcohol Depend; 2015 Mar; 148():47-55. PubMed ID: 25620732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the impact of medications for opioid use disorder at release from prison and jail settings: A microsimulation modeling study.
    Macmadu A; Adams JW; Bessey SE; Brinkley-Rubinstein L; Martin RA; Clarke JG; Green TC; Rich JD; Marshall BDL
    Int J Drug Policy; 2021 May; 91():102841. PubMed ID: 32712165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
    Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
    PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia.
    Moradmand-Badie B; Tran L; Oikarainen N; Degenhardt L; Nielsen S; Roberts J; Ward S; Bowman J; Larney S
    Drug Alcohol Rev; 2021 Jan; 40(1):98-108. PubMed ID: 32808357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.